Inflammatory processes in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex

K de Boer, Flip Jansen, Mark Nellist, S Redeker, Ans van den Ouweland, WGM Spliet, O van Nieuwenhuizen, D Troost, PB Crino, E Aronica

Research output: Contribution to journalArticleAcademicpeer-review

168 Citations (Scopus)

Abstract

Cortical tubers and subependymal giant cell tumors (SGCT) are two major cerebral. lesions associated with tuberous sclerosis complex (TSC). In the present study, we investigated immunocytochemically the inflammatory cell components and the induction of two major pro-inflammatory pathways (the interleukin (IL)-1 beta and complement pathways) in tubers and SGCT resected from TSC patients. All lesions were characterized by the prominent presence of microglial cells expressing class II-antigens (HLA-DR) and, to a lesser extent, the presence of CD68-positive macrophages. We also observed perivascular and parenchymal T lymphocytes (CD3(+)) with a predominance of CD8(+) T-cytotoxic/suppressor lymphoid cells. Activated microglia and reactive astrocytes expressed IL-1 beta and its signaling receptor IL-1RI, as well as components of the complement cascade, such as C1q, C3c and C3d. Albumin extravasation, with uptake in astrocytes, was observed in both tubers and SGCT, suggesting that alterations in blood brain barrier permeability are associated with inflammation in TSC-associated lesions. Our findings demonstrate a persistent and complex activation of inflammatory pathways in cortical tubers and SGCT. (C) 2007 Elsevier B.V. All rights reserved.
Original languageUndefined/Unknown
Pages (from-to)7-21
Number of pages15
JournalEpilepsy Research
Volume78
Issue number1
DOIs
Publication statusPublished - 2008

Research programs

  • EMC MGC-02-96-01

Cite this